or
Results for disorders and  
Showing 1 - 10 of 2843
3,4,5-Trialkoxybenzoyl alkanoic acids and their pharmaceutically-acceptable salts for prophylaxis and treatment of cardiac disorders.
Novel substituted phenylamidinourea compounds and processes for their preparation are disclosed. A method for the treatment of hypertensive disorders is also described.
Methods for treating certain cardiovascular disorders by administering 3-phenoxypyridine or a pharmaceutically acceptable acid-addition salt thereof.
Horse radish peroxidase (HRP) is treated with phenyl isothiocyanate (PITC) to block the free amino groups on the enzyme. The PITC derivative of HRP is treated with periodate to oxidize the carbohydrate moiety on the enzyme, thus generating aldehyde groups. Gamma G globulin fraction (IgG) purified from an anti-human IgE serum is conjugated to the peroxidase-aldehyde by formation of a Schiff's base between the aldehyde group on the enzyme and the amino groups on the IgG. The Schiff's base is stabi...
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-[2,3-b][1,5]benzodiazepine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of mental disorders. The compound has the following structure: ##STR1##
Method of and medicament for the treatment of disorders of the eye, namely, diabetic retinopathy and degenerative maculation of the eye wherein doses containing heparin in combination with detoxified enzymes obtained from the venom of snakes, especially the Brazilian vipers Bothrops Jararaca and Lachesis Atrox, is administered, each dose containing 2000 to 2500 I.U. of heparin in accordance with the French Pharmacopoeia and 1 to 2 coagulation units (K) of the enzyme. The composition is administe...
A method for temporarily enhancing libido in animals comprising administering to an animal an effective amount of a dopamine blocking compound and optionally administering simultaneously or concurrently an effective amount of a noradrenaline potentiating compound.
The present invention relates to a pharmaceutical composition providing a dosage unit of from 1 to 25 mg. of 3-(N,N-dimethylsulfamoyl)-5-(3-dimethylaminopropylidene)-5H-dibenzo[a,d]cy cloheptene or the corresponding 10,11-dihydro compound, and salts thereof useful as a skeletal muscle relaxant. It also relates to a method of treating muscular spasm and other similar muscular disorders associated with or caused by injury or arising spontaneously with no known cause by the administration of a phar...
A method for the treatment and/or prophylaxis of cerebrovascular disorders and/or disorders associated with cerebral senility in mammals, such as humans, which comprises administering to the mammal in need of such treatment and/or prophylaxis an effective and/or prophylactic amount of a compound of formula (I): ##STR1## wherein (i) R.sub.1 is a group --X--CO--CH.sub.3 where X is a hydrocarbon radical having up to 4 carbon atoms which may be substituted by a methyl group, R.sub.2 and R.sub.3, whi...
Skin disorders are controlled by irradiation with a mixture of a major portion of ultraviolet light of wave length in the 2537A area with almost to about as much infrared light, and a very small amount of visible light, derived from a filament-controlled 4-watt spheroidal-form mercury vapor lamp for a predetermined period of time. A preferred apparatus for the use of such lamps includes a plurality of lamps, including a central lamp, surrounded by a bank of similar lamps forming a square configu...
1 2 3 4 5 6 7 8 9 10
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us